2279 — Yonghe Medical Co Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$336.26m
- HK$742.96m
- CNY1.78bn
- 39
- 69
- 16
- 33
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 71.5 | 231 | 210 | -109 | -585 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 27.3 | 47.1 | 47 | -51.9 | 132 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -46 | 64.4 | -20.9 | -172 | 102 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 182 | 502 | 437 | -109 | -17.2 |
Capital Expenditures | -108 | -143 | -191 | -244 | -171 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 2.76 | 0.459 | -3.3 | -407 | 417 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -105 | -142 | -194 | -651 | 246 |
Financing Cash Flow Items | -1.27 | -4.87 | 1,092 | -33.9 | -2.34 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -55.8 | -156 | 1,028 | -333 | -185 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 21.3 | 203 | 1,273 | -1,001 | 38.1 |